Please ensure Javascript is enabled for purposes of website accessibility
Amgen Stock Quote


Price as of October 3, 2022, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Amgen Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AMGN +7.72% +22.19% +4.09% +163,768%
S&P -15.58% +44.95% +7.71% +2,171%

Amgen Company Info

One of the pioneers of the biotech industry, Amgen is now one of the world's largest pharmaceutical companies, with more than a dozen products focused on cancer, inflammation, neurology, cardiology, and more.

News & Analysis

The Fool has written over 1,000 articles on Amgen.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.